Sydney I. Ramirez

14.0k total citations · 1 hit paper
12 papers, 2.6k citations indexed

About

Sydney I. Ramirez is a scholar working on Infectious Diseases, Molecular Biology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Sydney I. Ramirez has authored 12 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Molecular Biology and 2 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Sydney I. Ramirez's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Sydney I. Ramirez is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Sydney I. Ramirez collaborates with scholars based in United States, Italy and South Korea. Sydney I. Ramirez's co-authors include Shane Crotty, Daniela Weiskopf, Alessandro Sette, Alba Grifoni, Davey M. Smith, April Frazier, José Mateus, Stephen A. Rawlings, Jennifer M. Dan and Aaron Sutherland and has published in prestigious journals such as Nature, Cell and Cancer Cell.

In The Last Decade

Sydney I. Ramirez

12 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

2020 2.2k citations Alba Grifoni, Daniela Weiskopf et al. Cell profile →

Peers

Countries citing papers authored by Sydney I. Ramirez

Since Specialization

Citations

This map shows the geographic impact of Sydney I. Ramirez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sydney I. Ramirez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sydney I. Ramirez more than expected).

Fields of papers citing papers by Sydney I. Ramirez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sydney I. Ramirez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sydney I. Ramirez. The network helps show where Sydney I. Ramirez may publish in the future.

Co-authorship network of co-authors of Sydney I. Ramirez

This figure shows the co-authorship network connecting the top 25 collaborators of Sydney I. Ramirez. A scholar is included among the top collaborators of Sydney I. Ramirez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sydney I. Ramirez. Sydney I. Ramirez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma 2025 ·Cancer Cell ·Simone Lubrano, Rodolfo Daniel Cervantes‐Villagrana, Farhoud Faraji, Sydney I. Ramirez, Kuniaki Sato, (unknown), Adam Officer, Nadia Arang, Damiano Cosimo Rigiracciolo, (unknown), Claudia Martini, (unknown), Fleur M. Ferguson, Antonietta Bacchiocchi, Ruth Halaban, Sílvia Coma, Sheri L. Holmen, Jonathan A. Pachter, (unknown), J. Silvio Gutkind	11
2	Immunological memory diversity in the human upper airway 2024 ·Nature ·Sydney I. Ramirez, Farhoud Faraji, (unknown), (unknown), Benjamin Goodwin, Hannah D. Stacey, Henry J. Sutton, Kathryn M. Hastie, Erica Ollmann Saphire, Hyun Jik Kim, Sara Mashoof, Carol H. Yan, Adam S. DeConde, (unknown), Shane Crotty	32
3	Abstract 4745: A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance 2024 ·Cancer Research ·Simone Lubrano, Farhoud Faraji, Rodolfo Daniel Cervantes‐Villagrana, Sydney I. Ramirez, Nadia Arang, Adam Officer, Damiano Cosimo Rigiracciolo, (unknown), (unknown), Ruth Halaban, Sílvia Coma, Sheri L. Holmen, Claudia Martini, Jonathan A. Pachter, Andrew E. Aplin, J. Silvio Gutkind	1
4	Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses 2022 ·JCI Insight ·Sydney I. Ramirez, Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji, Scott F. Sieg, Justin Ritz, Carlee Moser, Joseph J. Eron, Judith S. Currier, Paul Klekotka, Alessandro Sette, David A. Wohl, Eric S. Daar, Michael D. Hughes, Kara W Chew, Davey M. Smith, Shane Crotty	5
5	Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer 2022 ·Cells ·Farhoud Faraji, Sydney I. Ramirez, (unknown), (unknown), J. Silvio Gutkind	25
6	Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status 2022 ·Cell Host & Microbe ·Esther Dawen Yu, Eric Wang, (unknown), Benjamin Goodwin, Aaron Sutherland, Alison Tarke, James Chang, Rosa Isela Gálvez, José Mateus, Sydney I. Ramirez, Stephen A. Rawlings, Davey M. Smith, Gilberto Filaci, April Frazier, Daniela Weiskopf, Jennifer M. Dan, Shane Crotty, Alba Grifoni, Alessandro Sette, Ricardo da Silva Antunes	28
7	Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals breakdown → 2020 ·Cell ·Alba Grifoni, Daniela Weiskopf, Sydney I. Ramirez, José Mateus, Jennifer M. Dan, Carolyn Rydyznski Moderbacher, Stephen A. Rawlings, Aaron Sutherland, Lakshmanane Premkumar, Ramesh Jadi, Daniel Marrama, Aravinda M. de Silva, April Frazier, Aaron F. Carlin, Jason Greenbaum, Bjoern Peters, Florian Krammer, Davey M. Smith, Shane Crotty, Alessandro Sette	2241
8	Post‐transplant survey to assess patient experiences with donor‐derived HCV infection 2020 ·Transplant Infectious Disease ·(unknown), (unknown), Sydney I. Ramirez, Cathy Logan, Nancy Law, Kristin L. Mekeel, Victor Pretorius, Saima Aslam	8
9	Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence 2016 ·PLoS neglected tropical diseases ·Kaori Terasaki, Sydney I. Ramirez, Shinji Makino	17
10	Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin 2015 ·Journal of Virology ·Kumari G. Lokugamage, Krishna Narayanan, Keisuke Nakagawa, Kaori Terasaki, Sydney I. Ramirez, Chien‐Te K. Tseng, Shinji Makino	113
11	Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression 2014 ·Virus Research ·Krishna Narayanan, Sydney I. Ramirez, Kumari G. Lokugamage, Shinji Makino	141
12	Development of a Novel, Single-Cycle Replicable Rift Valley Fever Vaccine 2014 ·PLoS neglected tropical diseases ·Shin Murakami, Kaori Terasaki, Sydney I. Ramirez, John C. Morrill, Shinji Makino	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact